| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |